In human HCC, this can be in part explained by genomic amplification of the MDM4 gene locus at chromosome 1q32 as well as post-translational stabilization in the context of activated AKT/mTOR signaling [3,7,20]. Here, AKT1 is linked to hepatocellular carcinoma.